There is no reason for AVNR to be trading down here. Sure there was a reported loss, but uninformed investors and shorts are not reading that right. It was due to the heavy expenditures necessary to prepare for the commercial rollout of Nuerodex. Now that presriptions are actually being filled, the company will get that back fast and we will be profitable going forward.